Literature DB >> 2169858

Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy.

H Knecht1, R Sahli, P Shaw, C Meyer, E Bachmann, B F Odermatt, F Bachmann.   

Abstract

Epstein-Barr virus DNA was detected by the polymerase chain reaction (PCR) in five lymph node biopsies from eight patients with diagnosis of angioimmunoblastic lymphadenopathy (AILD). Three pairs of specific primers detected EBV DNA sequences near the 5' end (Bam W region), the middle (BMRF 1 region) and the 3' end (Eco RI D region) of the viral genome with equal accuracy when 1 microgram of DNA and 30 amplification cycles were used. When only 100 ng of DNA were screened with the BMRF 1 set of primers, a specific amplification product was still identifiable. The 593 base pair amplification product obtained using the Eco RI D set of primers was shown to contain an expected Sma I site at position 215, confirming the viral origin of the amplified sequence [corrected]. Our findings indicate that lymph nodes of AILD patients frequently harbour the entire EBV genome at a high percentage of at least 1 viral copy per 15,000 human cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169858     DOI: 10.1111/j.1365-2141.1990.tb07807.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

Review 1.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.

Authors:  H Herbst; F Dallenbach; M Hummel; G Niedobitek; S Pileri; N Müller-Lantzsch; H Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Miliary tuberculosis in a patient with Epstein-Barr virus-associated angioimmunoblastic lymphadenopathy.

Authors:  R Rho; T Laddis; C McQuain; J Selves; B Woda; H Knecht
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

4.  Familial primary gastric lymphoma.

Authors:  D Hayoz; M Extermann; B F Odermatt; P Pugin; C Regamey; H Knecht
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

5.  Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues.

Authors:  J Lorenzen; G Li; M Zhao-Höhn; C Wintzer; R Fischer; M L Hansmann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells.

Authors:  Y Shimaoka; J F Attrep; T Hirano; K Ishihara; R Suzuki; T Toyosaki; T Ochi; P E Lipsky
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

7.  Clonal Epstein-Barr virus genome in T-cell-rich lymphomas of B or probable B lineage.

Authors:  S L Loke; F Ho; G Srivastava; K H Fu; B Leung; R Liang
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

8.  A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas.

Authors:  S J Hamilton-Dutoit; G Pallesen
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

9.  Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.

Authors:  Z Estrov; R Kurzrock; E Pocsik; S Pathak; H M Kantarjian; T F Zipf; D Harris; M Talpaz; B B Aggarwal
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

10.  Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature.

Authors:  Toni K Roberts; Xueyan Chen; Jay Justin Liao
Journal:  Exp Hematol Oncol       Date:  2016-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.